Unknown

Dataset Information

0

Schlafen-11 (SLFN11): a step forward towards personalized medicine in small-cell lung cancer?

ABSTRACT:

SUBMITTER: Inno A 

PROVIDER: S-EPMC6328697 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Schlafen-11 (SLFN11): a step forward towards personalized medicine in small-cell lung cancer?

Inno Alessandro A   Stagno Anna A   Gori Stefania S  

Translational lung cancer research 20181201 Suppl 4

Similar Datasets

Unknown One step forward to personalized medicine?
| S-EPMC10652033 | biostudies-literature
Unknown Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer.
| S-EPMC9346119 | biostudies-literature
Unknown Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
| S-EPMC10524552 | biostudies-literature
Unknown Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
| S-EPMC3443151 | biostudies-literature
Unknown Improved MHC II epitope prediction - a step towards personalized medicine.
| S-EPMC7223749 | biostudies-literature
Unknown The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response.
| S-EPMC7921443 | biostudies-literature
Unknown Letetresgene autoleucel in advanced non-small cell lung cancer: a step towards truly personalized immunotherapy?
| S-EPMC12683410 | biostudies-literature
Unknown A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.
| S-EPMC8576031 | biostudies-literature
Unknown Exploiting MET dysregulation in EGFR-addicted non-small-cell lung carcinoma: a further step toward personalized medicine.
| S-EPMC6328682 | biostudies-literature
Unknown The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine.
| S-EPMC7281165 | biostudies-literature